Offering the BEST AST Enzymes. We proudly sell only the best systemic and digestive enzymes along with probiotic/prebiotics. All produced and manufactured in The United States. Contact us directly to order. Get same day free shipping

Saturday, January 19, 2019

Use this above "BUY Now" to direct order and pay $99 with Free Shipping (msrp $124.99)

Parkinson’s disease is an irreversible nervous system disorder that
primarily affects musculo-skeletal movement. While the progressive
disorder can cause stiffness and slow movements, signs and symptoms vary
greatly among patients.

Parkinson’s disease is caused by the gradual breakdown of brain
cells called neurons. The loss of neurons leads to a decrease in
dopamine levels, leading to abnormal brain activity. Only 5% of
Parkinson’s cases occur before the age of 40, with incidence increasing
with age. A majority of cases seem to be sporadic and of unknown origin –
however, like most diseases, there is a significant genetic component.

Recent theories about the causes of Parkinson’s disease are based on
abnormal fibrin production and deposition in the brain. Also known as
the “amyloid hypothesis,” researchers have been looking at the role of
abnormal protein aggregation in Parkinson’s and other neurodegenerative
disorders, like Alzheimer’s disease. There seems to be a correlation
between fibrin deposits and brain tissue degeneration, suggesting that
the fibrin contributes to cellular death in these diseases. Similar to
Alzheimer’s disease and Huntington’s disease, Parkinson’s disease
involves the mis-folding of a specific protein, eventually leading to
fibrin deposits.

There are several theories as to the underlying cause
of Parkinson’s, from oxidative damage to environmental toxins – but the
latest research seeks to understand why the dopamine-containing neurons
are affected so greatly. In fact, by the time a Parkinson’s patient
presents with symptoms, about 70% of the dopamine-containing neurons
have already been lost. Current therapies aim to address dopamine
deficiencies, but future therapies seek to address the prevention of
neuron degeneration (cellular death of the brain cells).Although systemic enzymes are implicated for the treatment of
Alzheimer’s disease, their use in similar neurodegenerative diseases has
yet to be studied. Specifically nattokinase, which has been shown to
directly dissolve the aggregated protein found in Alzheimer’s disease,
may be an option available to those suffering from Parkinson’s disease. Nattokinase is a natural systemic enzyme that helps to decrease fibrin
levels in the blood. Nattokinase is also able to reach areas where
fibrin has already accumulated – helping to restore blood flow and
inhibiting cellular death due to oxidative damage. Perhaps the most
promising aspect of systemic enzyme therapy is its ability to be used
concurrently with other medications. The only restriction is upon the
use of nattokinase, which should be discussed with a doctor prior to
adding it to a regimen with prescription blood thinners. However, it
should be noted that systemic enzymes do not cause adverse side effects
or drug-drug/drug-nutrient interactions.

Use this above "BUY Now" to direct order and pay $99 with Free Shipping (msrp $124.99)

Wednesday, January 16, 2019

Use the above BUY Now button pay $36.79 You get free shipping & 20% off

Because
probiotics contain live bacteria, it’s important to pay
attention to the shelf life. NOT ours! Floracor is the only shelf stable
ProBiotic and Prebiotic Formula. Now you are able to reap the full
benefits of FLORACOR-GI When you are looking for a probiotic, make sure it is a probiotic and prebiotic combined formula, like Floracor-GI. Probiotics work well when taken 30 mu=inutes before a meal with water. The prebiotics are important to aid the probitocs survival in the gastrointestinal system. This process stimulates the probiotics absorption and effectivenesss.

Use the above BUY Now button pay $36.79 You get free shipping & 20% off

Monday, January 14, 2019

Use the above BUY Now button

Get Free Shipping & 20%off

Supports respiratory & sinus systems

Amends mucus elasticity and viscosity without causing mucus depletion

Supports Muscle, joint and tissue health

Serrapeptase (Peptizyme-SP) for Healthy Fibrin MetabolismSerrapeptase a powerful systemic enzyme
that promotes total body support. Being the most powerful Serrapeptase
on the market, Serrapeptase is unrivaled among products of its kind
because it is packed with 130K SPU per capsule (80K is also available),
the strongest in the world.Serrapeptase – The bacterium, Serratia mercesans, produces the
enzyme serrapeptase to enable the silkworm to dissolve its silken cocoon
and emerge as a moth after metamorphosis. Serratia is now grown in
cultures to produce serrapeptase by fermentation.

What is enteric coating, and why is it needed?Enteric coating is a layer of protective
coating for dietary supplements that is meant to allow the supplement to
bypass digestion by the stomach and be absorbed in the small intestine.
Systemic enzymes are proteins, so their functional structures are
denatured (or destroyed) in conditions of extreme pH and temperature.
Without enteric coating, enzymes would be rendered useless long before
they reach the bloodstream, where their carry out their beneficial
effects.

Sunday, January 13, 2019

Use this above "BUY Now" to direct order and pay $99 with Free Shipping (msrp $124.99)

Parkinson’s disease is an irreversible nervous system disorder that
primarily affects musculo-skeletal movement. While the progressive
disorder can cause stiffness and slow movements, signs and symptoms vary
greatly among patients.

Parkinson’s disease is caused by the gradual breakdown of brain
cells called neurons. The loss of neurons leads to a decrease in
dopamine levels, leading to abnormal brain activity. Only 5% of
Parkinson’s cases occur before the age of 40, with incidence increasing
with age. A majority of cases seem to be sporadic and of unknown origin –
however, like most diseases, there is a significant genetic component.

Recent theories about the causes of Parkinson’s disease are based on
abnormal fibrin production and deposition in the brain. Also known as
the “amyloid hypothesis,” researchers have been looking at the role of
abnormal protein aggregation in Parkinson’s and other neurodegenerative
disorders, like Alzheimer’s disease. There seems to be a correlation
between fibrin deposits and brain tissue degeneration, suggesting that
the fibrin contributes to cellular death in these diseases. Similar to
Alzheimer’s disease and Huntington’s disease, Parkinson’s disease
involves the mis-folding of a specific protein, eventually leading to
fibrin deposits.

There are several theories as to the underlying cause
of Parkinson’s, from oxidative damage to environmental toxins – but the
latest research seeks to understand why the dopamine-containing neurons
are affected so greatly. In fact, by the time a Parkinson’s patient
presents with symptoms, about 70% of the dopamine-containing neurons
have already been lost. Current therapies aim to address dopamine
deficiencies, but future therapies seek to address the prevention of
neuron degeneration (cellular death of the brain cells).Although systemic enzymes are implicated for the treatment of
Alzheimer’s disease, their use in similar neurodegenerative diseases has
yet to be studied. Specifically nattokinase, which has been shown to
directly dissolve the aggregated protein found in Alzheimer’s disease,
may be an option available to those suffering from Parkinson’s disease. Nattokinase is a natural systemic enzyme that helps to decrease fibrin
levels in the blood. Nattokinase is also able to reach areas where
fibrin has already accumulated – helping to restore blood flow and
inhibiting cellular death due to oxidative damage. Perhaps the most
promising aspect of systemic enzyme therapy is its ability to be used
concurrently with other medications. The only restriction is upon the
use of nattokinase, which should be discussed with a doctor prior to
adding it to a regimen with prescription blood thinners. However, it
should be noted that systemic enzymes do not cause adverse side effects
or drug-drug/drug-nutrient interactions.

Use this above "BUY Now" to direct order and pay $99 with Free Shipping (msrp $124.99)

Saturday, January 12, 2019

Use this above "BUY Now" to direct order and pay $99 with Free Shipping (msrp $124.99)

Fibromyalgia

Before the 70's, fibromyalgia was most
commonly known as fibrositis, where “itis” implied an
inflammatory component. Despite the understanding of
inflammatory pathways to pain, clinical research was unable to identify
the role of inflammation in fibromyalgia for many years.Within the last decade, fibromyalgia research has once again been
focusing on the possible contribution of inflammation to disease
progression, and is finding some new and interesting results.Clinical studies have produced evidence that fibromyalgia is
associated with the immune system’s improper regulation of
proinflammatory cytokines that circulate in the bloodstream,
contributing to the dysfunction of the central nervous system and
pain-related neurotransmitters. Cytokines, depending on their
concentration, induce symptoms, such as fatigue, fever, sleep, pain, and
muscle pain, all of which develop in fibromyalgia patients.These findings are uncovering new possibilities in research for
fibromyalgia causation, as well as treatment options. Some experimental
pain reduction therapies have been examined and shown positive results,
correlating with decreased proinflammatory cytokine levels.
Anticonvulsant drugs, analgesics, opiods and anti-depressants are
commonly prescribed to fibromyalgia patients, but tend to carry side
effects reflective of the syndrome itself,and many of which lack evidence for effectiveness.Limited treatment options have led to an increasing use of systemic
enzyme therapy as a means to alleviate symptoms and improve quality of
life. Certain proteolytic (protein digesting) enzymes have been
identified to have extremely beneficial actions when applied to
inflammation and pain related to this condition.

It has long been known that people with chronic muscle pain or
fibromyalgia have more fibrin in their tissues and blood. This fibrin,
while initially helpful in the early stages of healing after an injury,
can become problematic if the body does not clear itself of the agent
after it has done its work.Fibromyalgia sufferers experience micro-tears in their muscles from
the normal activity of daily living — each and every day. But because
the average fibromyalgia patient does not achieve and stay in stage 4
delta sleep at rest, growth hormone is not produced in enough quantities
to heal these tears, which leads to more fibrin buildup.

For the most part, people with fibromyalgia do not have a strong
enzymatic capacity for producing enzymes that break down fibrin. This leads to a buildup of fibrin,
which over time catches red blood cells in a web of restriction. This
fibrin causes a restriction of blood flow. Red blood cells
literally become stuck, disabling them from getting into the capillaries
to oxygenate and nourish the muscles where the metabolic waste that
causes pain is removed.The body uses fibrin to help heal itself after an injury. However, if
you have poor blood flow and a lack of enzyme activity, fibrin will
start to accumulate. If the injured area is slow to heal, fibrin
accumulation appears as clumps of scar tissue in the muscles or at a
surgical site.Ultimately, if excess fibrin is present throughout the circulatory
system, blood flow is restricted to areas of the body that need it most.
Over time, the body compensates for this restriction by increasing its
blood pressure. People with excess fibrin suffer from chronic fatigue,
slow healing, inflammation and pain, as well as elevated blood pressure.Proteolytic enzymes taken on an empty stomach break down these
proteins into their smallest elements. The enzymes pass through the
stomach and intestinal lining, and enter the bloodstream where they
begin the process of breaking down the buildup in the muscles,
connective tissue and blood. These enzymes bring nutrition and
oxygen-rich blood that can remove the metabolic waste produced by
inflammation and excess fibrin.Serrapeptase has been proven to be the strongest of the proteolytic
enzymes, inducing anti-inflammatory, fibrinolytic and anti-edemic
(prevents swelling and fluid retention) activity in a number of tissues.Using enzymes to clear your body of fibrin takes time. It takes years
to develop webs of fibrin in your tissues — so be patient, log your
usage and, over time, notice how much less pain and how much more
flexibility you have.Serrapeptase has demonstrated anti-inflammatory and fibrinolytic
activity, and acts rapidly on localized inflammation with no reports of
adverse effects.

Bromelain, a proteolytic enzyme
extracted from pineapple, has also been found to be effective in
reducing inflammation by blocking cytokine production and activity

Digestive Enzymes Support:

Fat Digestion*

Cardiovascular Health*

Absorption of Fish & Omega Oils*

Gallbladder Function*

Nutrient Absorption*

Lipase-HP Plus

How well do you breakdown the fat that you eat?Fat or lipids are heavily consumed in
the average diet. Some of these fats are healthy and some are not quite
as beneficial to our health. Regardless of the dietary nutritional value
of the types of fat we consume, it is essential to properly break them
down for our body to either utilize or remove. Dietary fats can be
difficult to properly break down: first, because they are large
molecules, and secondly, because they are not water soluble.

Factors such as age, stress or
lifestyle choices can affect the production of enzymes to support proper
digestion, such as lipase (fat-digesting enzyme), and vital fluids such
as bile.

Lipases are a class of enzymes
responsible for the breakdown of fats within the digestive system.
Produced by the liver and stored in the gallbladder, bile salts function
in breaking down larger molecule of fats (triglycerides), allowing more
surface for lipid to efficiently break down fats. Once properly broken
down, they move along the lining of the small intestine for further
processing, and are then absorbed.

When the digestive system does not
produce or secrete adequate amounts of lipase to accommodate dietary fat
intake, symptoms like bloating, cramping, flatulence, undesired weight
gain, and sometimes steatorrhea (fat in the stool) may occur. Lipases
are produced primarily by the pancreas as pancreatic enzymes. If the
pancreas isn’t functioning properly, it is likely to cause fat
maldigestion and malabsorption, which results poor nutritional
absorption.

Serrapeptase
is a powerful systemic enzyme that promotes total body support. Serrapeptase is
a powerful proteolytic enzyme derived from the bacteria found in the intestine of
silkworms. Known for its beneficial immune cell response, with 80,000 SPU, it is one of the strongest on the market.

Excellacor contains enteric-coated serrapeptase, a key ingredient in fibrin
metabolism. The enteric-coated allows the enzymes to bypass the acidic
environment of the stomach and reach the small intestine, where absorption
occurs. Without enteric coating, enzymes will denature in the stomach, and
simply be a really expensive digestive enzyme. Excellacor break down proteins
and amino acid chains, promoting total body support. This supports a healthy
response to inflammation, fatigued muscles, joint function, and promotes fibrin
metabolism.

Serracor-NK
is a powerful blend of enteric-coated serrapeptase and Nattokinase. Systemic
enzymes known for their fibrinolytic properties, with antioxidant herbs,
CoEnzymeQ10 and magnesium. Serracor-NK supports a healthy circulatory system
& normal fibrin metabolism. Supports
the body’s natural response to inflammation including respiratory and sinus,
and cardiovascular health.